Page 67 - Read Online

Page 16 of 17 Gulati et al. Metab Target Organ Damage 2024;4:9 https://dx.doi.org/10.20517/mtod.2023.45

45. Rutledge SM, Soper ER, Ma N, et al. Association of HSD17B13 and PNPLA3 with liver enzymes and fibrosis in Hispanic/latino
individuals of diverse genetic ancestries. Clin Gastroenterol Hepatol 2023;21:2578-87.e11. DOI
46. Young KA, Palmer ND, Fingerlin TE, et al. Genome-wide association study identifies loci for liver enzyme concentrations in Mexican
Americans: The guardian consortium. Obesity 2019;27:1331-7. DOI PubMed PMC
47. Walker RW, Belbin GM, Sorokin EP, et al. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients
from a multi-ethnic biobank. J Hepatol 2020;72:1070-81. DOI PubMed PMC
48. Kallwitz ER, Tayo BO, Kuniholm MH, et al. American ancestry is a risk factor for suspected nonalcoholic fatty liver disease in
Hispanic/latino adults. Clin Gastroenterol Hepatol 2019;17:2301-9. DOI
49. Wang J, Conti DV, Bogumil D, et al. Association of genetic risk score with NAFLD in an ethnically diverse cohort. Hepatol Commun
2021;5:1689-703. DOI PubMed PMC
50. Kallwitz E, Tayo BO, Kuniholm MH, et al. Association of HSD17B13 rs72613567:TA with non-alcoholic fatty liver disease in
Hispanics/Latinos. Liver Int 2020;40:889-93. DOI PubMed
51. Jiao J, Kwan SY, Sabotta CM, et al. Circulating fatty acids associated with advanced liver fibrosis and hepatocellular carcinoma in
South Texas Hispanics. Cancer Epidemiol Biomarkers Prev 2021;30:1643-51. DOI PubMed PMC
52. Mazi TA, Borkowski K, Fiehn O, et al. Plasma oxylipin profile discriminates ethnicities in subjects with non-alcoholic steatohepatitis:
an exploratory analysis. Metabolites 2022;12:192. DOI PubMed PMC
53. Mazi TA, Borkowski K, Newman JW, et al. Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high
NAFLD rate and severity in Hispanic Americans, a pilot study. Free Radic Biol Med 2021;172:490-502. DOI PubMed PMC
54. Rausch JC, Lavine JE, Chalasani N, et al; NASH Clinical Research Network. Genetic variants associated with obesity and insulin
resistance in Hispanic boys with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2018;66:789-96. DOI PubMed PMC
55. Umano GR, Caprio S, Di Sessa A, et al. The rs626283 variant in the MBOAT7 gene is associated with insulin resistance and fatty liver
in caucasian obese youth. Am J Gastroenterol 2018;113:376-83. DOI
56. Nichols PH, Pan Y, May B, et al. Effect of TSH on non-alcoholic fatty liver disease (NAFLD) independent of obesity in children of
predominantly Hispanic/Latino ancestry by causal mediation analysis. PLoS One 2020;15:e0234985. DOI PubMed PMC
57. Wu H, Zhu L, Kinnear D, Triggs N, Quintanilla NM, Himes R. Clinical, laboratory, and histologic correlates of serum antinuclear
antibody in Hispanic pediatric patients with nonalcoholic fatty liver disease. Am J Clin Pathol 2022;158:221-7. DOI PubMed
58. Frediani JK, Naioti EA, Vos MB, Figueroa J, Marsit CJ, Welsh JA. Arsenic exposure and risk of nonalcoholic fatty liver disease
(NAFLD) among United States adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014. Environ
Health 2018;17:6. DOI PubMed PMC
59. Verstraete SG, Wojcicki JM, Perito ER, Rosenthal P. Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in
Hispanic adolescents in NHANES 2003-2010. Environ Health 2018;17:12. DOI PubMed PMC
60. Chen R, Xu Y, Xu C, et al. Associations between mercury exposure and the risk of nonalcoholic fatty liver disease (NAFLD) in US
adolescents. Environ Sci Pollut Res Int 2019;26:31384-91. DOI PubMed
61. Han S, Sung GH, Lee S, Han KJ, Han HJ. Serum cadmium is associated with hepatic steatosis and fibrosis: Korean national health and
nutrition examination survey data IV-VII. Medicine 2022;101:e28559. DOI PubMed PMC
62. Jones DH, Yu X, Guo Q, Duan X, Jia C. Racial disparities in the heavy metal contamination of urban soil in the Southeastern United
States. Int J Environ Res Public Health 2022;19:1105. DOI PubMed PMC
63. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31. DOI PubMed
64. Juanola O, Martínez-López S, Francés R, Gómez-Hurtado I. Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and
environmental risk factors. Int J Environ Res Public Health 2021;18:5227. DOI PubMed PMC
65. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a
largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124-31. DOI
66. Ryu S, Chang Y, Jung HS, et al. Relationship of sitting time and physical activity with non-alcoholic fatty liver disease. J Hepatol
2015;63:1229-37. DOI
67. Caviglia GP, Rosso C, Fagoonee S, Saracco GM, Pellicano R. Liver fibrosis: the 2017 state of art. Panminerva Med 2017;59:320-31.
DOI PubMed
68. Mota M, Banini BA, Cazanave SC, Sanyal AJ. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver
disease. Metabolism 2016;65:1049-61. DOI PubMed PMC
69. Chen H, Wang J, Li Z, et al. Consumption of sugar-sweetened beverages has a dose-dependent effect on the risk of non-alcoholic fatty
liver disease: an updated systematic review and dose-response meta-analysis. Int J Environ Res Public Health 2019;16:2192. DOI
PubMed PMC
70. Baratta F, Pastori D, Polimeni L, et al. Adherence to mediterranean diet and non-alcoholic fatty liver disease: effect on insulin
resistance. Am J Gastroenterol 2017;112:1832-9. DOI
71. Kim D, Vazquez-Montesino LM, Li AA, Cholankeril G, Ahmed A. Inadequate physical activity and sedentary behavior are
independent predictors of nonalcoholic fatty liver disease. Hepatology 2020;72:1556-68. DOI PubMed
72. Heredia NI, Zhang X, Balakrishnan M, et al. Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-
sectional study in a representative sample of United States adults using NHANES 2017-2018. Prev Med 2022;154:106903. DOI
PubMed PMC
73. Heredia NI, Zhang X, Balakrishnan M, Hwang JP, Thrift AP. Association of lifestyle behaviors with non-alcoholic fatty liver disease